EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selective rolling circle amplification detection of site-specific DNA 5-hydroxymethylcytosine

Ningning Dong, Qing Hong, Xin Sui, Jie Yan, Yaping Gao, Zehua Wang, Yao Luo, Yanru Qin

Frontiers in Immunology · 2026

DOI: 10.3389/fimmu.2026.1960016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Ningning Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: 5-Methylcytosine, Nucleic Acid Amplification Techniques, DNA Methylation. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Site-specific 5-hydroxymethylcytosine (5hmC) has been identified as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. However, directly distinguishing trace levels of 5hmC from its highly abundant cytosine/5-methylcytosine (C/5mC) analogs remains a technical challenge. Herein, we present a 5hmC selective ligation-rolling circle amplification (5hmC-RCA) that enables the direct, high-specificity discrimination of 5hmC from C/5mC. The high specificity of 5hmC-RCA depends on the high selectivity of HiFi Taq DNA Ligase, which exhibits robust tolerance for mismatched 5hmC/A base pairs, thereby efficiently ligating the associated nicking site. While the mismatched 5mC/A or C/A pairs fail to be recognized by HiFi Taq DNA Ligase. As a proof of principle, the 5hmC-RCA assay was evaluated for its performance using Septin9 gene, which considered as key biomarkers in the prognosis and diagnosis of CRC, as the target, demonstrating a detection sensitivity of approximately 0.5%. Notably, the assay exhibited no cross-reactivity with unmodified target even at a high background concentration of 5,000 copies per reaction. By coupling HiFi Taq DNA Ligase-mediated high selective ligation with RCA, sensitive and selective quantification of site-specific 5hmC is achieved. Due to the simplicity of 5hmC-RCA, it also has potential for use in cfDNA originating from the tumor microenvironment and immune cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5-MethylcytosineNucleic Acid Amplification TechniquesDNA MethylationHumansSeptinsBiomarkers, Tumor

Stichwörter der Autor:innen

5-hydroxymethylcytosineDNA methylationHiFi Taq DNA Ligaseepigenetic biomarkerlateral flow dipstickrolling circle amplificationsite-specific detectiontumor microenvironment

Substanzen

5-Methylcytosine5-hydroxymethylcytosineSeptinsBiomarkers, TumorSEPTIN9 protein, human

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Laboratory Medicine, Sichuan Medical Laboratory Clinical Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.

Zitieren

APA

Dong, N., Hong, Q., Sui, X., Yan, J., Gao, Y., Wang, Z., Luo, Y., & Qin, Y. (2026). Selective rolling circle amplification detection of site-specific DNA 5-hydroxymethylcytosine. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1960016

Vancouver

Dong N, Hong Q, Sui X, Yan J, Gao Y, Wang Z, et al. Selective rolling circle amplification detection of site-specific DNA 5-hydroxymethylcytosine. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1960016

BibTeX
@article{Dong2026,
  author = {Dong, Ningning and Hong, Qing and Sui, Xin and Yan, Jie and Gao, Yaping and Wang, Zehua and Luo, Yao and Qin, Yanru},
  title = {Selective rolling circle amplification detection of site-specific DNA 5-hydroxymethylcytosine},
  journal = {Frontiers in Immunology},
  year = {2026},
  doi = {10.3389/fimmu.2026.1960016}
}
Kostenlos starten →